Profile of tivantinib and its potential in the treatment of hepatocellular carcinoma: the evidence to date

Autor:	Pievsky D, Pyrsopoulos N
Jazyk:	angličtina
Rok vydání:	2016
Předmět:	Tivantinib ARQ-197 Hepatocellular carcinoma Met inhibitor Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	Journal of Hepatocellular Carcinoma, Vol Volume 3, Pp 69-76 (2016)
Druh dokumentu:	article
ISSN:	2253-5969
Popis:	Daniel Pievsky,1 Nikolaos Pyrsopoulos2 1Department of Internal Medicine, 2Division of Gastroenterology and Hepatology, Rutgers New Jersey Medical School, University Hospital, Newark, NJ, USA Abstract: Hepatocellular carcinoma (HCC) is the fastest rising cause of cancer-related death in the United States and carries a very poor prognosis, with a median survival time of
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/f8b154212b714f0999186bc887851f6d Zobrazit plný text záznamu View record in DOAJ